Baidu
map

病例分享:淋巴浆细胞淋巴瘤/华氏巨球蛋白血症?一例分析

2017-12-06 承德医学院附属医院检验科 杨新宏 检验视界网

患者男,68岁,主因:左侧胸痛5个月,呼吸困难半个月入院。

患者男,68岁,主因:左侧胸痛5个月,呼吸困难半个月入院。

一、病例特点:

1. 青年男性,既往体健。
 
2. 慢性起病病史5个月,病前无诱因,主要表现为左侧胸痛,伴有少许咳嗽、咳痰,1个月前于外院诊断为“左侧肋软骨炎”,给予对症处理,无好转。半个月前无明显诱因患者出现呼吸困难,夜间加重,为进一步诊治入院。

3. 体格检查:发育正常,营养中等,正常面容,神清语利,精神差,查体合作。全身皮肤黏膜无黄染、出血点、紫癜及瘀斑。周身淋巴结未触及肿大。咽无充血,扁桃体无肿大。胸骨无压痛,左肺呼吸音弱,可闻及散在湿啰音。服软,无压痛,肝脾未触及。双下肢中度水肿。

4. 辅助检查:WBC 8.18×10^9/L, RBC 2.8574×10^12/L, HB 92g/L, PLT 129×10^9/L,中性粒细胞比率60.5%,淋巴细胞比率34.4%,单核细胞比率4.9%。网织百分比1.3%。

免疫球蛋白M(IgM)39.20 g/L, IgG、IgA均正常。

血Kappa轻链591.00 mg/dl, 血Lambda轻链114.00 mg/dl。

尿Kappa轻链15.80 mg/dl, 尿Lambda轻链0.74 mg/dl。

铁蛋白(FERR)189.70 ng/ml, 叶酸(FA)10.96 nmol/l, 维生素B12(B12)725.50 pmol/l。

男性肿瘤标志物均正常。

总蛋白(TP)87.1g/l, 白蛋白(ALB)34.7g/l,碱性磷酸酶(ALP)181.00 U/L, 钾(K)3.00mmol/l, 氯(CL)93.00mmol/l,尿素氮(BUN)11.04mmol/l,肌酐(CRE)195.40 umol/l。血糖(GLU)7.41mmol/l。余生化指标正常。

N短脑钠肽前体6090pg/ml。

促红细胞生成素(EPO)177.08 mIU/ml。

二、初步诊断及诊断依据

1.多发性骨髓瘤:是以恶性的单克隆性浆细胞异常增生,并分泌大量的单克隆性免疫球蛋白或其片段,发生骨质破坏和其它系统损害。本患者免疫球蛋白M(IgM)39.20 g/L,血Kappa轻链591.00 mg/dl,尿Kappa轻链15.80 mg/dl,尿Lambda轻链0.74 mg/dl。贫血,肾功能异常。待完善骨髓穿刺及活检明确诊断。

2.巨球蛋白血症:是骨髓中淋巴样浆细胞大量克隆性增生所致,M蛋白为IgM,无骨质破坏,与IgM型多发性骨髓瘤不同。待完善骨髓象、流式、MYD88基因检测助诊。

3.意义未明单克隆球蛋白血症:该病除有M蛋白外并无其他临床表现,无骨骼病变,骨髓中浆细胞增多不明显,单克隆免疫球蛋白一般低于骨髓瘤的诊断标准,且历数年无变化,β2微球蛋白水平正常,该患者与之不符。

4.其他产生M蛋白的疾病:如重链病,慢性B淋巴细胞白血病,B细胞淋巴瘤,原发性淀粉样变和反应性单克隆球蛋白增多等,自身免疫性疾病,但这些疾病多不具有诊断骨髓瘤的依据。待骨髓象等结果助诊。

三、骨髓象分析

增生活跃,粒系增生减低,形态大致正常。红系增生减低,成熟红细胞緍钱状排列。淋巴细胞比例增高占87.0%,胞体小,圆形,边缘整齐或有细小的突起;浆量少或极少,淡蓝色;核圆形,染色聚集成块状;未见核仁。全片共见巨核细胞5个,均为成熟无血小板形成巨核细胞。血小板成堆分布。浆细胞占1.0%,阅片过程中可见2-3个小堆分布的成熟浆细胞。血片:白细胞正常。粒细胞比例、形态大致正常。成熟红细胞緍钱状排列。计数100个白细胞未见有核红细胞。淋巴细胞比例34%,形态正常。单核细胞比例减低、形态正常。血小板成堆分布。

大组化四项:过氧化物酶(POX):阴性。幼稚细胞糖原染色(PAS):69%弥散细颗粒状弱阳性。非特异性酯酶染色(NAE):15%弱阳性。非特异性酯酶染色+NaF(NAE+NAF):8%弱阳性。

意见:1.浆细胞疾病(多发性骨髓瘤)?

2.淋巴细胞增殖性疾病:淋巴浆细胞淋巴瘤(LPL)/巨球蛋白血症(WM)?

请结合临床、流式、染色体核型分析、基因等相关检查。

骨髓细胞图片如下:

  

四、免疫分型

骨髓中可见异常细胞群约占有核细胞的0.25%,表达CD38, cKappa, CD81, 部分表达CD27, CD138, 弱表达CD45,不表达CD117,CD19,cLambda, CD28, CD200, CD56, CD20, 为异常浆细胞表型。另可见异常细胞群占有核细胞的62.38%,表达cKappa, CD19, 弱表达CD5,CD20,CD200,不表达CD138,CD38,cLambda, CD28,CD81,CD117,CD56,CD27,CD10,CD103,为异常B淋巴细胞表型。结论:B淋巴细胞和一群异常浆细胞,异常B淋巴细胞占有核细胞的62.38%,FSC及SSC均为偏小,为CD5+CD10-小B细胞淋巴瘤伴浆细胞分化?

五、43种融合基因检测

融合基因MYD88-L265P阳性。

结合患者流式及基因检测结果考虑诊断:淋巴浆细胞淋巴瘤/华氏巨球蛋白血症。

备注:

CD5+CD10-小B细胞淋巴瘤表型常见于慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CLL/SLL)、套细胞淋巴瘤(MCL)。

95%的MCL具有t(11;14)(q13;q32)易位,易位使IGH基因重排时A-D-J连接发生错误,导致11 q13上的BCL1癌基因与14 q32的IGH基因重排,BCL1基因易位于IGH基因调节片段附近,累及BCL1断裂点远端的110bp的CCND1基因。CCND1基因重排或(和)高表达是MCL的特征,是MCL与其它淋巴瘤鉴别的重要指标。

MYD88L265P突变广泛存在于华氏蛋白血症(WM)患者中,突变率可达96%,也可见于其他小B细胞淋巴瘤、弥漫大B细胞淋巴瘤等。而在多发性骨髓瘤、边缘区淋巴瘤及CLL等中无表达或罕见表达,可作为WM的辅助诊断依据,但非特异性指标。

淋巴浆细胞淋巴瘤(LPL)是具有浆细胞样分化特征的小B细胞淋巴瘤,病理特点为小淋巴细胞、浆细胞样淋巴细胞、浆细胞的肿瘤性增生,多侵犯骨髓、亦可浸润淋巴结、脾脏,常伴有单克隆丙种球蛋白血症,多数为IgM型。其中95%LPL累及骨髓,同时伴有IgM型单克隆丙种球蛋白血症,被称为华氏巨球蛋白血症(WM)。

原发性巨球蛋白血症

国内诊断标准(参考血液病诊断及疗效标准,第三版,张之南)

1.临床表现

(1)老年患者有不明原因贫血及出血倾向。

(2)有高黏滞综合征表现(视力障碍、肾功能损害、神经系统症状)或雷诺现象。

(3)肝、脾、淋巴结肿大。

2.试验室检查

(1)血清中单克隆IgM>0g/L。

(2)可有贫血、白细胞减少及血小板减少。

(3)骨髓、肝、脾、淋巴结中有浆细胞样淋巴细胞浸润。免疫荧光法检查可见该细胞表面及胞浆含IgM。

(4)血清黏滞度增高。

发病年龄、血清中单克隆IgM>10g/L及骨髓中浆细胞样淋巴细胞浸润是诊断本病的必要依据。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2054065, encodeId=5a28205406505, content=<a href='/topic/show?id=3e6d65960f3' target=_blank style='color:#2F92EE;'>#淋巴浆细胞淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65960, encryptionId=3e6d65960f3, topicName=淋巴浆细胞淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Apr 30 12:40:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035156, encodeId=ca48203515627, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Sep 25 02:40:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1702449, encodeId=6d401e02449f6, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77951, encryptionId=ddc9e795159, topicName=细胞淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=201630414353, createdName=marlenexl, createdTime=Tue Mar 27 07:40:00 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466603, encodeId=4d2e1466603d1, content=<a href='/topic/show?id=8d3e65434d4' target=_blank style='color:#2F92EE;'>#浆细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65434, encryptionId=8d3e65434d4, topicName=浆细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=181c6846356, createdName=huangshifeng, createdTime=Fri Dec 08 12:40:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267793, encodeId=1b4426e793d7, content=诊断详细.思路清晰, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/22/1442d9106653d5d3fe5964c51c353c1d.jpg, createdBy=62dd2153454, createdName=2066xq, createdTime=Fri Dec 08 10:47:19 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267499, encodeId=4f3926e49975, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Thu Dec 07 08:14:19 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267486, encodeId=e2ba26e486ff, content=好全, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d63b2215083, createdName=120e3578m17暂无昵称, createdTime=Thu Dec 07 07:51:32 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267364, encodeId=938426e36471, content=学了........, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Wed Dec 06 23:05:41 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267353, encodeId=c06226e3538a, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Wed Dec 06 22:41:56 CST 2017, time=2017-12-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2054065, encodeId=5a28205406505, content=<a href='/topic/show?id=3e6d65960f3' target=_blank style='color:#2F92EE;'>#淋巴浆细胞淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65960, encryptionId=3e6d65960f3, topicName=淋巴浆细胞淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Apr 30 12:40:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035156, encodeId=ca48203515627, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Sep 25 02:40:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1702449, encodeId=6d401e02449f6, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77951, encryptionId=ddc9e795159, topicName=细胞淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=201630414353, createdName=marlenexl, createdTime=Tue Mar 27 07:40:00 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466603, encodeId=4d2e1466603d1, content=<a href='/topic/show?id=8d3e65434d4' target=_blank style='color:#2F92EE;'>#浆细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65434, encryptionId=8d3e65434d4, topicName=浆细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=181c6846356, createdName=huangshifeng, createdTime=Fri Dec 08 12:40:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267793, encodeId=1b4426e793d7, content=诊断详细.思路清晰, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/22/1442d9106653d5d3fe5964c51c353c1d.jpg, createdBy=62dd2153454, createdName=2066xq, createdTime=Fri Dec 08 10:47:19 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267499, encodeId=4f3926e49975, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Thu Dec 07 08:14:19 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267486, encodeId=e2ba26e486ff, content=好全, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d63b2215083, createdName=120e3578m17暂无昵称, createdTime=Thu Dec 07 07:51:32 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267364, encodeId=938426e36471, content=学了........, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Wed Dec 06 23:05:41 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267353, encodeId=c06226e3538a, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Wed Dec 06 22:41:56 CST 2017, time=2017-12-06, status=1, ipAttribution=)]
    2018-09-25 xzw113
  3. [GetPortalCommentsPageByObjectIdResponse(id=2054065, encodeId=5a28205406505, content=<a href='/topic/show?id=3e6d65960f3' target=_blank style='color:#2F92EE;'>#淋巴浆细胞淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65960, encryptionId=3e6d65960f3, topicName=淋巴浆细胞淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Apr 30 12:40:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035156, encodeId=ca48203515627, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Sep 25 02:40:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1702449, encodeId=6d401e02449f6, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77951, encryptionId=ddc9e795159, topicName=细胞淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=201630414353, createdName=marlenexl, createdTime=Tue Mar 27 07:40:00 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466603, encodeId=4d2e1466603d1, content=<a href='/topic/show?id=8d3e65434d4' target=_blank style='color:#2F92EE;'>#浆细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65434, encryptionId=8d3e65434d4, topicName=浆细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=181c6846356, createdName=huangshifeng, createdTime=Fri Dec 08 12:40:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267793, encodeId=1b4426e793d7, content=诊断详细.思路清晰, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/22/1442d9106653d5d3fe5964c51c353c1d.jpg, createdBy=62dd2153454, createdName=2066xq, createdTime=Fri Dec 08 10:47:19 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267499, encodeId=4f3926e49975, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Thu Dec 07 08:14:19 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267486, encodeId=e2ba26e486ff, content=好全, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d63b2215083, createdName=120e3578m17暂无昵称, createdTime=Thu Dec 07 07:51:32 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267364, encodeId=938426e36471, content=学了........, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Wed Dec 06 23:05:41 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267353, encodeId=c06226e3538a, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Wed Dec 06 22:41:56 CST 2017, time=2017-12-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2054065, encodeId=5a28205406505, content=<a href='/topic/show?id=3e6d65960f3' target=_blank style='color:#2F92EE;'>#淋巴浆细胞淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65960, encryptionId=3e6d65960f3, topicName=淋巴浆细胞淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Apr 30 12:40:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035156, encodeId=ca48203515627, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Sep 25 02:40:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1702449, encodeId=6d401e02449f6, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77951, encryptionId=ddc9e795159, topicName=细胞淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=201630414353, createdName=marlenexl, createdTime=Tue Mar 27 07:40:00 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466603, encodeId=4d2e1466603d1, content=<a href='/topic/show?id=8d3e65434d4' target=_blank style='color:#2F92EE;'>#浆细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65434, encryptionId=8d3e65434d4, topicName=浆细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=181c6846356, createdName=huangshifeng, createdTime=Fri Dec 08 12:40:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267793, encodeId=1b4426e793d7, content=诊断详细.思路清晰, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/22/1442d9106653d5d3fe5964c51c353c1d.jpg, createdBy=62dd2153454, createdName=2066xq, createdTime=Fri Dec 08 10:47:19 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267499, encodeId=4f3926e49975, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Thu Dec 07 08:14:19 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267486, encodeId=e2ba26e486ff, content=好全, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d63b2215083, createdName=120e3578m17暂无昵称, createdTime=Thu Dec 07 07:51:32 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267364, encodeId=938426e36471, content=学了........, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Wed Dec 06 23:05:41 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267353, encodeId=c06226e3538a, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Wed Dec 06 22:41:56 CST 2017, time=2017-12-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2054065, encodeId=5a28205406505, content=<a href='/topic/show?id=3e6d65960f3' target=_blank style='color:#2F92EE;'>#淋巴浆细胞淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65960, encryptionId=3e6d65960f3, topicName=淋巴浆细胞淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Apr 30 12:40:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035156, encodeId=ca48203515627, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Sep 25 02:40:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1702449, encodeId=6d401e02449f6, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77951, encryptionId=ddc9e795159, topicName=细胞淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=201630414353, createdName=marlenexl, createdTime=Tue Mar 27 07:40:00 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466603, encodeId=4d2e1466603d1, content=<a href='/topic/show?id=8d3e65434d4' target=_blank style='color:#2F92EE;'>#浆细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65434, encryptionId=8d3e65434d4, topicName=浆细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=181c6846356, createdName=huangshifeng, createdTime=Fri Dec 08 12:40:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267793, encodeId=1b4426e793d7, content=诊断详细.思路清晰, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/22/1442d9106653d5d3fe5964c51c353c1d.jpg, createdBy=62dd2153454, createdName=2066xq, createdTime=Fri Dec 08 10:47:19 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267499, encodeId=4f3926e49975, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Thu Dec 07 08:14:19 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267486, encodeId=e2ba26e486ff, content=好全, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d63b2215083, createdName=120e3578m17暂无昵称, createdTime=Thu Dec 07 07:51:32 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267364, encodeId=938426e36471, content=学了........, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Wed Dec 06 23:05:41 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267353, encodeId=c06226e3538a, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Wed Dec 06 22:41:56 CST 2017, time=2017-12-06, status=1, ipAttribution=)]
    2017-12-08 2066xq

    诊断详细.思路清晰

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2054065, encodeId=5a28205406505, content=<a href='/topic/show?id=3e6d65960f3' target=_blank style='color:#2F92EE;'>#淋巴浆细胞淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65960, encryptionId=3e6d65960f3, topicName=淋巴浆细胞淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Apr 30 12:40:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035156, encodeId=ca48203515627, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Sep 25 02:40:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1702449, encodeId=6d401e02449f6, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77951, encryptionId=ddc9e795159, topicName=细胞淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=201630414353, createdName=marlenexl, createdTime=Tue Mar 27 07:40:00 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466603, encodeId=4d2e1466603d1, content=<a href='/topic/show?id=8d3e65434d4' target=_blank style='color:#2F92EE;'>#浆细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65434, encryptionId=8d3e65434d4, topicName=浆细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=181c6846356, createdName=huangshifeng, createdTime=Fri Dec 08 12:40:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267793, encodeId=1b4426e793d7, content=诊断详细.思路清晰, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/22/1442d9106653d5d3fe5964c51c353c1d.jpg, createdBy=62dd2153454, createdName=2066xq, createdTime=Fri Dec 08 10:47:19 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267499, encodeId=4f3926e49975, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Thu Dec 07 08:14:19 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267486, encodeId=e2ba26e486ff, content=好全, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d63b2215083, createdName=120e3578m17暂无昵称, createdTime=Thu Dec 07 07:51:32 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267364, encodeId=938426e36471, content=学了........, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Wed Dec 06 23:05:41 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267353, encodeId=c06226e3538a, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Wed Dec 06 22:41:56 CST 2017, time=2017-12-06, status=1, ipAttribution=)]
    2017-12-07 三生有幸9135

    学习一下谢谢分享

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2054065, encodeId=5a28205406505, content=<a href='/topic/show?id=3e6d65960f3' target=_blank style='color:#2F92EE;'>#淋巴浆细胞淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65960, encryptionId=3e6d65960f3, topicName=淋巴浆细胞淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Apr 30 12:40:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035156, encodeId=ca48203515627, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Sep 25 02:40:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1702449, encodeId=6d401e02449f6, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77951, encryptionId=ddc9e795159, topicName=细胞淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=201630414353, createdName=marlenexl, createdTime=Tue Mar 27 07:40:00 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466603, encodeId=4d2e1466603d1, content=<a href='/topic/show?id=8d3e65434d4' target=_blank style='color:#2F92EE;'>#浆细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65434, encryptionId=8d3e65434d4, topicName=浆细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=181c6846356, createdName=huangshifeng, createdTime=Fri Dec 08 12:40:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267793, encodeId=1b4426e793d7, content=诊断详细.思路清晰, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/22/1442d9106653d5d3fe5964c51c353c1d.jpg, createdBy=62dd2153454, createdName=2066xq, createdTime=Fri Dec 08 10:47:19 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267499, encodeId=4f3926e49975, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Thu Dec 07 08:14:19 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267486, encodeId=e2ba26e486ff, content=好全, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d63b2215083, createdName=120e3578m17暂无昵称, createdTime=Thu Dec 07 07:51:32 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267364, encodeId=938426e36471, content=学了........, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Wed Dec 06 23:05:41 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267353, encodeId=c06226e3538a, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Wed Dec 06 22:41:56 CST 2017, time=2017-12-06, status=1, ipAttribution=)]
    2017-12-07 120e3578m17暂无昵称

    好全

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2054065, encodeId=5a28205406505, content=<a href='/topic/show?id=3e6d65960f3' target=_blank style='color:#2F92EE;'>#淋巴浆细胞淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65960, encryptionId=3e6d65960f3, topicName=淋巴浆细胞淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Apr 30 12:40:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035156, encodeId=ca48203515627, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Sep 25 02:40:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1702449, encodeId=6d401e02449f6, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77951, encryptionId=ddc9e795159, topicName=细胞淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=201630414353, createdName=marlenexl, createdTime=Tue Mar 27 07:40:00 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466603, encodeId=4d2e1466603d1, content=<a href='/topic/show?id=8d3e65434d4' target=_blank style='color:#2F92EE;'>#浆细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65434, encryptionId=8d3e65434d4, topicName=浆细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=181c6846356, createdName=huangshifeng, createdTime=Fri Dec 08 12:40:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267793, encodeId=1b4426e793d7, content=诊断详细.思路清晰, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/22/1442d9106653d5d3fe5964c51c353c1d.jpg, createdBy=62dd2153454, createdName=2066xq, createdTime=Fri Dec 08 10:47:19 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267499, encodeId=4f3926e49975, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Thu Dec 07 08:14:19 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267486, encodeId=e2ba26e486ff, content=好全, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d63b2215083, createdName=120e3578m17暂无昵称, createdTime=Thu Dec 07 07:51:32 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267364, encodeId=938426e36471, content=学了........, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Wed Dec 06 23:05:41 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267353, encodeId=c06226e3538a, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Wed Dec 06 22:41:56 CST 2017, time=2017-12-06, status=1, ipAttribution=)]
    2017-12-06 135****7952平儿

    学了........

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2054065, encodeId=5a28205406505, content=<a href='/topic/show?id=3e6d65960f3' target=_blank style='color:#2F92EE;'>#淋巴浆细胞淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65960, encryptionId=3e6d65960f3, topicName=淋巴浆细胞淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Mon Apr 30 12:40:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035156, encodeId=ca48203515627, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Sep 25 02:40:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1702449, encodeId=6d401e02449f6, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77951, encryptionId=ddc9e795159, topicName=细胞淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=201630414353, createdName=marlenexl, createdTime=Tue Mar 27 07:40:00 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466603, encodeId=4d2e1466603d1, content=<a href='/topic/show?id=8d3e65434d4' target=_blank style='color:#2F92EE;'>#浆细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65434, encryptionId=8d3e65434d4, topicName=浆细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=181c6846356, createdName=huangshifeng, createdTime=Fri Dec 08 12:40:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267793, encodeId=1b4426e793d7, content=诊断详细.思路清晰, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/22/1442d9106653d5d3fe5964c51c353c1d.jpg, createdBy=62dd2153454, createdName=2066xq, createdTime=Fri Dec 08 10:47:19 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267499, encodeId=4f3926e49975, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Thu Dec 07 08:14:19 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267486, encodeId=e2ba26e486ff, content=好全, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d63b2215083, createdName=120e3578m17暂无昵称, createdTime=Thu Dec 07 07:51:32 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267364, encodeId=938426e36471, content=学了........, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Wed Dec 06 23:05:41 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267353, encodeId=c06226e3538a, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Wed Dec 06 22:41:56 CST 2017, time=2017-12-06, status=1, ipAttribution=)]
    2017-12-06 changjiu

    学习一下谢谢

    0

相关资讯

“淋巴浆细胞淋巴瘤/华氏巨球蛋白血症诊断与治疗中国专家共识(2016年版)”解读

2016年中国抗癌协会血液肿瘤委员会、中华医学会血液学分会白血病淋巴瘤学组和中国抗淋巴瘤联盟组织国内专家共同制定了“淋巴浆细胞淋巴瘤/华氏巨球蛋白血症诊断与治疗中国专家共识2016年版”。限于篇幅,本共识仅仅给出了涉及淋巴浆细胞淋巴瘤/WM诊断和治疗最为重要的信息。另外,由于血液科医师在临床上更多见的是WM,而非淋巴浆细胞淋巴瘤。因此,在此结合共识内容对WM进行进一步介绍,以提高大家对此类少见疾病

2016淋巴浆细胞淋巴瘤/华氏巨球蛋白血症诊断与治疗中国专家共识发布

淋巴浆细胞淋巴瘤/华氏巨球蛋白血症(lymphoplasmacytic lymphoma / Waldenströmmacroglobulinemia,LPL/WM)是一种少见的惰性成熟B细胞淋巴瘤,在非霍奇金淋巴瘤中所占比例<2%。近年来国际上对LPL/WM发病机制、诊断和治疗的研究均取得较大进展,而国内对LPL/WM认识较晚,对其诊断、治疗比较混乱,为提高我国临床工作者对LPL/WM的认

Baidu
map
Baidu
map
Baidu
map